CARL vs MDT
CARL: Carlsmed is a medical technology company revolutionizing spinal surgery with AI-enabled, patient-specific implants that improve outcomes and surgical precision. MDT: Medtronic is a global healthcare technology leader dedicated to alleviating pain, restoring health, and extending life through innovative medical devices and digital solutions.
Side-by-side fundamentals
| Metric | CARL | MDT | Edge |
|---|---|---|---|
| Price as of 2026-10-21 close | $14.31 | $93.03 | |
| Market cap | $391M | $119.0B | |
| P/E as of 2026-10-21 | n/a | 22.91 | |
| PEG as of 2026-10-21, 3-year EPS CAGR to FY2026 | n/a | 2.35 | |
| Net margin FY2026, SEC XBRL | n/a | +13.2% | |
| Operating margin FY2026, SEC XBRL | n/a | +17.8% | |
| ROE | -30.0% | +9.7% | MDT higher |
| ROA | -22.8% | +5.2% | MDT higher |
| Debt / equity | 0.18 | 0.56 | CARL lower |
| Revenue growth (YoY) FY2026, SEC XBRL | n/a | +8.4% | |
| Revenue CAGR (3y) SEC XBRL | n/a | +5.2% | |
| Dividend yield as of 2026-09-03 | n/a | +3.1% | |
| Dividend streak (yrs) SEC XBRL | 0 | 14 | MDT higher |
| Beta as of 2026-09-03 | 1.26 | 0.35 | |
| 1-year return as of 2026-10-21 close | +1.5% | -2.9% | CARL higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.